Ardagh Metal Packaging (AMBP)

The Take — The court cleared the sale path, not the math. Use today's pop to sell the yield.

What moved the stock today. AMBP is up ~7% intraday ($4.33 → $4.63) after reports that a Luxembourg judge lifted the order that had blocked Ardagh Holdings (AHSA) from selling its ~76% stake. Dissenting ARD Finance PIK noteholders obtained that order ex parte in September, and AHSA had been challenging it. The ruling reopens the Evercore-run sale process. It does not create a bid. No buyer, price or timetable has been disclosed, and the noteholders could still keep litigating. The "€2.74B" figure in the headlines is a press valuation of the unit, not an offer. Nothing about operations, guidance or the balance sheet changed today.

What changed vs the 10/14 build. Price +8% ($4.27 → $4.63), so the premium to base widened from +84% to +97%. Base value is $2.35, versus $2.32 yesterday. No input changed: the model was rebuilt and its terminal NOPAT treatment differs by about 0.5%. The rebuilt scenario engine also fades scenario growth toward terminal, which moves the bear case to $0.59 (was $0.41) and the bull case to $4.12 (was $4.26). One correction: yesterday's report said the price needed ~$899M of normalized EBITDA. That figure was inconsistent with the model's own sensitivity (~$0.54/share per $50M). At today's price, the DCF needs ~$982M of normalized EBITDA forever, which is +26% vs the FY26 guide midpoint of $782M. Alternatively it needs a 6.8% WACC on a B3-rated, 5x-levered issuer. The market now pays 8.85x 2026E EBITDA (was 8.6x). Our DCF is worth 6.7x.

The low PEG is a mirage. The screen's PEG of ~0.77 rests on EPS growth from a near-zero base (trailing P/E ~80x), flattered by one-time items such as the tariff refund. Those items do not recur. We value EBITDA and FCFF, which strip them out. Caveat: I could not find the refund quantified in the Q2-26 release, so I have not modelled it.

The equity is still a thin sliver on a $4.2B debt stack. Net debt including leases is $4,155M, or 5.2x LTM EBITDA. Moody's puts AMP above 7x on its adjusted basis, with negative cash flow, and specifically flags the ~$240M/yr dividend. Book equity is −$750M. The $0.40 dividend costs $239M a year against ~$62M of 2026 FCF after interest, leases and capex. 2021–25 FCF after leases totalled −$187M, while $1.04B was paid out in dividends. One more point for minority holders: AMP estimates ~$30M/yr of standalone costs if the AHSA services agreement ends in a sale. That is ~$0.40/share at 8x, and it lands on AMP's P&L unless a strategic buyer absorbs it.

The bull case is a sale, and today's price already pays for most of it. A strategic buyer at 9.25x 2026E EBITDA would pay $5.15, only 11% above today. Even if we raise the takeout probability from 15% to 25%, the probability-weighted value is $2.79. The asymmetry is ~$0.50 of upside if a full-company deal prints, against ~$2 of downside if the process stalls, AHSA sells its stake privately with no minority premium, or the dividend is cut.

Call: Holders: today's pop is the exit. Trim or exit into $4.60–5.00. Sell or avoid above ~$3.50. Accumulate only below ~$2.50 (≈ base, where even a halved dividend yields ~8%). Do not short it outright. A whole-company takeout at 9–10x would print $5–6 overnight, and the ruling makes that more plausible. A bearish view with defined risk: a Jan-27 $4.50/$3.50 put spread, never financed with a short call. Holders who want to wait for the sale: write Jan-27 $5 covered calls, which caps you near the takeout value while you collect the premium. Next print: Q3-26 around Oct 22 (Ardagh Group reports 10/22; AMP has not confirmed a separate date). The Q3 EBITDA guide is $200–210M against $208M a year ago, so watch for the dividend and any sale update.